Hepatitis B vaccine - Berna BiotechAlternative Names: HBV vaccine - Berna Biotech; Therapeutic hepatitis B vaccine - Berna Biotech
Latest Information Update: 22 Oct 2009
At a glance
- Originator Berna Biotech
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 26 Jan 2004 Phase-III clinical trials in Hepatitis B treatment in Switzerland (unspecified route)
- 30 Dec 2002 Preclinical trials in Hepatitis B treatment in Switzerland (unspecified route)